LRRK2 and Parkinson disease: Far fewer patients with iPD had been genotyped for DNM3 rs2421947 in the PD GWAS cohort (Table 1), though for DNM3 rs2421947 was not associated with AAO risk in iPD cases with the LRRK2 rs10878226 risk variant (beta = 0.045, se = 0.53, p = 0.93, n = 3300) nor without (beta = 0.21, se = 0.31, p = 0.69, n = 9822).